Search
Close this search box.

Ascendiant Capital Markets, LLC

Ascendiant News

See Our Impact

Need capital to meet your growth plans? Get in touch with our team today!

Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $30,000,000 At-the-Market (ATM) Offering for BioSig Technologies, Inc. (Nasdaq: BSGM)

JUPITER, Florida – September 18, 2023 — Ascendiant Capital Markets LLC (“Ascendiant”) announced today the filing of a $30,000,000 At-the-Market (ATM) Offering for BioSig Technologies, Inc. (Nasdaq: BSGM) of Westport, Connecticut.

Ascendiant is serving as Sole Sales Agent on the financing transaction. For a copy of this announcement, click here.

Share this post with your friends:

Facebook
Twitter
LinkedIn

Want to stay up-to-date with the latest at Ascendiant? Subscribe to our mailing list!

Newsletter Form (#2)

See other recent news

October 7, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $6,500,000 At-the-Market (ATM) Offering for Alzamend Neuro, Inc. (Nasdaq: ALZN)
September 30, 2024
Ascendiant Capital Markets LLC announced today the filing of a $1,075,000 At-the-Market (ATM) Offering for Aclarion, Inc. (Nasdaq: ACON) of Broomfield, Colorado
September 16, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $2,600,000 At-the-Market (ATM) Offering for Auddia Inc. (Nasdaq: AUUD)
September 12, 2024
Ascendiant Serves as Financial Advisor on $2,510,000 Private Placement for Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS)
September 9, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for Allarity Therapeutics, Inc. (Nasdaq: ALLR) Increased to $50,000,000
September 3, 2024
Ascendiant Completes 23rd Year in Business, Moves Forward Into Year 24
August 26, 2024
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $3,150,000 Private Placement for Allarity Therapeutics, Inc. (Nasdaq: ALLR)
August 19, 2024
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $8,250,000 Private Placement for Quantum Computing Inc. (Nasdaq: QUBT)
August 12, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for The Singing Machine Company, Inc. (Nasdaq: MICS) Increased to $3,100,000
August 5, 2024
Ascendiant Initiates Equity Research Coverage on MIRA Pharmaceuticals, Inc. (Nasdaq: MIRA)
July 29, 2024
Ascendiant Initiates Equity Research Coverage on Aclarion, Inc. (Nasdaq: ACON)
July 9, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for The Singing Machine Company, Inc. (Nasdaq: MICS) Increased to $2,020,000